BioLife Solutions Files 8-K on Security Holder Vote

TL;DR

BioLife Solutions filed an 8-K about a shareholder vote. Details TBD.

AI Summary

BioLife Solutions, Inc. filed an 8-K on August 6, 2024, reporting on a matter submitted to a vote of its security holders as of August 1, 2024. The filing does not contain specific details about the vote's outcome or the proposals presented.

Why It Matters

This filing indicates a formal process involving shareholder decisions, which could impact corporate governance and future strategic directions for BioLife Solutions.

Risk Assessment

Risk Level: low — The filing is procedural and does not disclose immediate financial or operational risks.

Key Players & Entities

• BioLife Solutions, Inc. (company) — Registrant
• August 1, 2024 (date) — Earliest event reported
• August 6, 2024 (date) — Date of report
• Delaware (jurisdiction) — State of incorporation
• Bothell, WA (location) — Principal executive offices

FAQ

Key Financial Figures

• $0.001 — ich registered Common Stock, par value $0.001 per share BLFS The NASDAQ Stock Market

Filing Documents

• blfs-20240801.htm (8-K) — 39KB
• 0001628280-24-035254.txt ( ) — 159KB
• blfs-20240801.xsd (EX-101.SCH) — 2KB
• blfs-20240801_lab.xml (EX-101.LAB) — 21KB
• blfs-20240801_pre.xml (EX-101.PRE) — 12KB
• blfs-20240801_htm.xml (XML) — 3KB

07 Submission of Matters to a Vote of Security Holders

Item 5.07 Submission of Matters to a Vote of Security Holders. On August 1, 2024, BioLife Solutions, Inc. (the "Company") held its 2024 annual meeting of stockholders (the "Annual Meeting"). Only stockholders of record as of the close of business on June 3, 2024 (the "Record Date") were entitled to vote at the Annual Meeting. As of the Record Date, there were 46,068,755 shares of the Company's common stock outstanding and entitled to vote at the Annual Meeting. The number of shares of the Company's common stock present or represented by valid proxy at the Annual Meeting was 41,648,093. As addressed below, at the Annual Meeting, the Company's stockholders (i) re-elected each of Roderick de Greef, Joydeep Goswami, Amy DuRoss, Rachel Ellingson, and Timothy Moore as directors, (ii) approved, on a non-binding, advisory basis, the compensation of the Company's named executive officers, and (iii) ratified the appointment by the audit committee of the Company's board of directors (the "Audit Committee") of Grant Thornton LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The following is a tabulation of the voting on the proposals presented at the Annual Meeting: Proposal No. 1 – Election of directors. Roderick de Greef, Joydeep Goswami, Amy DuRoss, Rachel Ellingson, and Timothy Moore were elected to serve until the 2025 annual meeting of stockholders and until his or her successor is duly elected and qualified, unless he or she resigns, is removed or otherwise is disqualified from serving as a director of the Company. The voting results were as follows: Nominee Shares Voted For Shares Withheld Broker Non-Votes Roderick de Greef 37,301,209 388,516 3,958,368 Joydeep Goswami 23,884,582 13,805,143 3,958,368 Amy DuRoss 36,431,877 1,257,848 3,958,368 Rachel Ellingson 23,047,426 14,642,299 3,958,368 Timothy Moore 36,885,165 804,560 3,958,368 Proposal No. 2 – Approval, on a non-binding, advisory basis, of th

View Full Filing

View this 8-K filing on SEC EDGAR